Literature DB >> 17849480

On the origin of bladder sensing: Tr(i)ps in urology.

Wouter Everaerts1, Thomas Gevaert, Bernd Nilius, Dirk De Ridder.   

Abstract

The mammalian TRP family consists of 28 channels that can be subdivided into 6 different classes: TRPV (vanilloid), TRPC (canonical), TRPM (Melastatin), TRPP (Polycystin), TRPML (Mucolipin), and TRPA (Ankyrin). TRP channels are activated by a diversity of physical (voltage, heat, cold, mechanical stress) or chemical (pH, osmolality) stimuli and by binding of specific ligands, enabling them to act as multifunctional sensors at the cellular level. Currently, a lot of scientific research is devoted to these channels and their role in sensing mechanisms throughout the body. In urology, there's a growing conviction that disturbances in afferent (sensory) mechanisms are highly important in the pathogenesis of functional problems. Therefore, the TRP family forms an interesting new target to focus on. In this review we attempt to summarize the existing knowledge about TRP channels in the urogenital tract. So far, TRPV1, TRPV2, TRPV4, TRPM8, and TRPA1 have been described in different parts of the urogenital tract. Although only TRPV1 (the vanilloid receptor) has been extensively studied so far, more evidence is slowly accumulating about the role of other TRP channels in the (patho)physiology of the urogenital tract. (c) 2007 Wiley-Liss, Inc

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 17849480     DOI: 10.1002/nau.20511

Source DB:  PubMed          Journal:  Neurourol Urodyn        ISSN: 0733-2467            Impact factor:   2.696


  50 in total

Review 1.  From urgency to frequency: facts and controversies of TRPs in the lower urinary tract.

Authors:  Roman Skryma; Natalia Prevarskaya; Dimitra Gkika; Yaroslav Shuba
Journal:  Nat Rev Urol       Date:  2011-10-04       Impact factor: 14.432

2.  The supraspinal neural correlate of bladder cold sensation--an fMRI study.

Authors:  Ulrich Mehnert; Lars Michels; Monika-Zita Zempleni; Brigitte Schurch; Spyros Kollias
Journal:  Hum Brain Mapp       Date:  2010-05-24       Impact factor: 5.038

3.  Does ivabradine exhibit a role in the reduction of bladder overactivity?

Authors:  K Stamatiou; I Heretis; E Skoumbourdis
Journal:  Int Urol Nephrol       Date:  2008       Impact factor: 2.370

4.  [Male and female urinary incontinence from the viewpoint of the pelvic floor surgeon].

Authors:  B Liedl
Journal:  Urologe A       Date:  2010-02       Impact factor: 0.639

Review 5.  Bladder sensory physiology: neuroactive compounds and receptors, sensory transducers, and target-derived growth factors as targets to improve function.

Authors:  Eric J Gonzalez; Liana Merrill; Margaret A Vizzard
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2014-04-23       Impact factor: 3.619

Review 6.  Changes in afferent activity after spinal cord injury.

Authors:  William C de Groat; Naoki Yoshimura
Journal:  Neurourol Urodyn       Date:  2010       Impact factor: 2.696

7.  Functional role for Piezo1 in stretch-evoked Ca²⁺ influx and ATP release in urothelial cell cultures.

Authors:  Tatsuya Miyamoto; Tsutomu Mochizuki; Hiroshi Nakagomi; Satoru Kira; Masaki Watanabe; Yasunori Takayama; Yoshiro Suzuki; Schuichi Koizumi; Masayuki Takeda; Makoto Tominaga
Journal:  J Biol Chem       Date:  2014-04-23       Impact factor: 5.157

Review 8.  Potential therapeutic value of transient receptor potential channels in male urogenital system.

Authors:  Gamze Toktanis; Ecem Kaya-Sezginer; Didem Yilmaz-Oral; Serap Gur
Journal:  Pflugers Arch       Date:  2018-09-07       Impact factor: 3.657

9.  Functional characterization of transient receptor potential channels in mouse urothelial cells.

Authors:  Wouter Everaerts; Joris Vriens; Grzegorz Owsianik; Giovanni Appendino; Thomas Voets; Dirk De Ridder; Bernd Nilius
Journal:  Am J Physiol Renal Physiol       Date:  2009-12-16

10.  [Overactive bladder in the elderly].

Authors:  T Bschleipfer; F M Wagenlehner; G Lüdecke; A Pilatz; W Weidner
Journal:  Urologe A       Date:  2013-06       Impact factor: 0.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.